Rob Brierley is Editor-in-Chief of The Lancet Gastroenterology & Hepatology. Rob studied molecular and cellular biochemistry and clinical pharmacology at the University of Oxford, and clinical oncology at the University of Birmingham. Rob has worked in the publishing industry since graduation, first as a technical editor for the Journal of Molecular Biology, before working on a series of viral hepatitis textbooks for a book publishers. Rob joined The Lancet Group in 2004, first at The Lancet Infectious Diseases and The Lancet, before I joining The Lancet Oncology as Senior Editor in 2008 and then Deputy Editor in 2012. The Lancet Gastroenterology & Hepatology launched in 2016. Rob’s interests include gastrointestinal and hepatobiliary cancers, viral hepatitis, and inflammatory bowel diseases.
